mRNA |
palmostatin B |
CTRPv2 |
pan-cancer |
AAC |
-0.08 |
0.07 |
mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
0.053 |
0.07 |
mRNA |
carboplatin:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.067 |
0.08 |
mRNA |
temsirolimus |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.08 |
mRNA |
Nilotinib |
GDSC1000 |
pan-cancer |
AAC |
-0.067 |
0.08 |
mRNA |
Zibotentan |
GDSC1000 |
pan-cancer |
AAC |
-0.061 |
0.08 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.062 |
0.08 |
mRNA |
FSC231 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.08 |
mRNA |
KIN001-270 |
GDSC1000 |
pan-cancer |
AAC |
0.06 |
0.08 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.08 |